增强抗生素耐药细菌感染疗法:具有多种抗菌机制的自组装双子四元氨基功能化片纳米组件
Yuanyuan He1, Xiao Wang1, Shanshan He2
1College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Med-X center of materials, Sichuan University, Chengdu, Sichuan 610065, China.
ACS nano
|February 12, 2025
概括
一种新的基于的纳米材料 (WA) 3GQA8C,通过破坏它们的膜和抑制蛋白质合成,有效地对抗耐药细菌. 这种创新的抗微生物药物在治疗有毒性降低和抗药性潜力下降的感染方面显示出前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,需要新的治疗策略.
- 基于的纳米材料由于其独特的特性,为开发新的抗菌剂提供了有希望的途径.
研究的目的:
- 通过将双子四元化合物 (GQAs) 与设计的六化物结合,设计和合成新型的阴离子抗微生物纳米材料.
- 评估开发的纳米材料对抗药物耐药性病原体的抗菌疗效,细胞毒性和耐药性潜力.
主要方法:
- (WA) 3GQA8C的自组装成纳米粒子.
- 在体外抗菌活性测定对抗耐药细菌菌株.
- 在体内研究,包括小鼠的皮下和急性腹膜炎感染模型.
- 机械研究涉及细菌膜完整性,脂相互作用和核糖体功能.
主要成果:
- 自组装的 (WA) 3GQA8C纳米颗粒显示出强大的抗菌活性,对抗药物耐药的低细胞毒性病原体.
- 在体内研究表明,WA) 3GQA8C显著降低了感染小鼠的细菌负担和器官损伤,表现优于vancomycin.
- 机械研究表明,WA3GQA8C通过向和变形酸盐 (PG) 来破坏细菌膜,并干扰脂蛋白贩运,同时也抑制核糖体功能.
结论:
- 开发的 (WA) 3GQA8C纳米材料代表了基于的抗微生物药物的合理设计策略.
- 这种方法为打击抗微生物药物耐药性感染日益增长的威胁提供了有希望的解决方案.
- (WA) 3GQA8C具有独特的多模式作用机制,降低了耐药性发展的可能性.
相关概念视频
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...